Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Challenging conventional wisdom: How to reduce the risk of Alzheimer’s disease

Arnold R. Eiser, MD
Conditions
January 29, 2023
26 Shares
Share
Tweet
Share

Alzheimer’s disease is a devastating illness without effective treatment. Yet it may, in fact, be largely preventable. The first shocking fact to absorb is that the pathogenesis is largely extracranial, though assuredly not entirely so. That clearly defies the conventional pharmacologic wisdom, which has obsessed with amyloid-beta as the offending agent and has approached it by crafting and evaluating antibodies against it. The FDA has even bought into that theory and approved drugs based on a reduction in amyloid deposits and the slightest slowing of cognitive decline.

But if one examines amyloid-beta, one finds it possesses anti-microbial properties in itself. Is that perhaps not a clue that we are dealing with a dysfunctional immune system with a possible role of common infections ranging from food mouth flora to herpes viruses? Many neuroscientists believe that is so but find their research approach difficult to get funded because the dominant theory still holds sway over the funding agencies, although there are some signs that may be changing finally.

I entered the fray as I researched and wrote the book Preserving Brain Health in a Toxic Age: New Insights from Neuroscience, Integrative Medicine and Public Health  as well as several scholarly articles. My understanding evolved through a complex nexus of gut-brain, liver-brain, gut-immune, endocrine-immune, and nutrient-immune interactions to develop a comprehensive view. I also saw that environmental toxicants have a substantial role in pathogenesis, including heavy metals, volatile organic compounds, herbicides, and PM 2.5. A healthy microbiome, a well-functioning liver, an endocrine system free of insulin resistance and lessening the decline in DHEA, and provision of adequate vitamins and essential trace elements are all necessary for an intact blood-brain barrier (BBB) and a well-functioning set of neuron support cells, the microglia and astrocytes.

Having been in academic medicine for four decades in a variety of roles and having pretty much challenged conventional wisdom for all that time, I was still taken aback by the difficulty of getting these insights their proper attention. This ship that is the clinical research juggernaut does not take turning around easily, especially when doing so may hurt its rather enormous profit margin.

So how does one prevent Alzheimer’s?

1. Start by eating a Mediterranean diet or a Japanese diet, i.e., a diet that is anti-inflammatory (which seems to have worked for Tom Brady in defying aging). What’s more, it also reduces the lethality of  COVID too. Adequate micronutrients like selenium and zinc, as well as vitamins, are essential but too much of them can be toxic too.

2. Exercise throughout your lifetime or at least since middle age, and be sure to sweat when exercising, as that is a major means of toxin excretion.

3. Avoid biotoxins like BMAA secreted by blue-green algae, really cyanobacteria. To do so, you will need to recognize what it looks like to avoid it on lakes and streams. Also, avoid toxicants like mercury or arsenic that harm the gut-immune-brain nexus. The latter can be found in water in many states, while the former is unfortunately common in fish, a food usually associated with brain health. Sorry, even an excess of essential metals like copper and iron can damage the BBB. Probably toss that no-stick frying pan, too (PFAS, an endocrine disruptor which may also be harmful).

4. Avoid tobacco products and moderate alcohol consumption to minimize these sources of toxins.

Probably not all AD would be eliminated but most likely more than half, although following these steps may be easier said than done.

None of these steps requires a new patented drug to avoid AD, which may be the problem in getting this approach accepted by the medical world, which has a Pavlovian response to RCTs virtually controlled by Pharma. When I explained this view to a medical journalist, she asked how this would be monetized. Oops, as a retiree, I was not focused on that. I had given talks on this subject for medical grand rounds, neurology grand rounds, and gerontology grand rounds both nationally and internationally to some acclaim. However, one chairman did not like it when I indicated from a brain health perspective, two days a week of alcohol abstinence is preferable.

My friends comforted me that change of this nature takes time and organizational support, so that recognition will be slow at best. I am not looking for any glory in this, just some real change that would reduce the suffering engendered by AD and related disorders. Besides a huge number of scientists throughout the world have contributed to these insights. I also would like general recognition of environmental toxins by allopathic medicine because it is a common cause of many disorders besides neurodegenerative disorders, including many cancers and heart, lung, and renal diseases.

Finally, I need to qualify my earlier statement that there is no effective treatment for AD. There may well be one for early AD and mild cognitive impairment, often a pre-stage of AD. Dale Bredesen, MD, a long-time dementia researcher, had developed a multifaceted individualized intervention based on a battery of clinical tests that cover the gamut of items, many of which I have discussed above. He has taught physicians his protocol for doing so now through the Institute for Functional Medicine and compiled some impressive pilot results published in  July 2022. Based on my study of the available neuroscientific evidence, I can only offer an opinion that this approach may well be effective. Still, I fully understand the call for more detailed studies with suitable controls and robust, detailed reports before it can be considered an effective treatment.

So while the ship of AD clinical research may be turning slowly, we need to understand the mercantile nature of research and treatment on both sides of this divide. One longs for medical science to be free of such financial considerations, but that does not appear to be possible. Nevertheless, we must understand that the profit motive is not always beneficial to advancing the science of discovery. To put it another way, the scientific reality is not concerned with our society’s financial organization and its needs. So we have this disease with no known cure and clear obstacles to attaining it. But a path to prevention is clearer and perhaps the more reasonable ask.

Arnold R. Eiser is an internal medicine physician and author of Preserving Brain Health in a Toxic Age: New Insights from Neuroscience, Integrative Medicine, and Public Health.

Prev

The $6 soup that saved a pregnant patient $20,000

January 29, 2023 Kevin 2
…
Next

Forgiveness vs. self-preservation: the difficult decision of caring for an abusive parent

January 29, 2023 Kevin 0
…

Tagged as: Neurology

Post navigation

< Previous Post
The $6 soup that saved a pregnant patient $20,000
Next Post >
Forgiveness vs. self-preservation: the difficult decision of caring for an abusive parent

More by Arnold R. Eiser, MD

  • Paracelsus and the birth of toxicology

    Arnold R. Eiser, MD
  • a desk with keyboard and ipad with the kevinmd logo

    How the postmodern ethos challenges medical professionalism

    Arnold R. Eiser, MD

Related Posts

  • Gun violence is our society’s disease

    Leslie Mattson, MD
  • Timely treatment decisions: the promise of surrogate markers

    Layla Parast, PhD
  • Is social media a friend or foe of science?

    Michael Joyce, MD
  • My first patient to be diagnosed with cancer

    Ton La, Jr., MD, JD
  • Hormone replacement therapy is still linked to cancer

    Martha Rosenberg
  • The culture of perfection in medicine is a disease

    Andy Cruz, MD

More in Conditions

  • A complex patient interviews a retired physician

    Ann McColl and James Whitlock, MD
  • Burnout on the U.S.S. Enterprise

    Arthur Lazarus, MD, MBA
  • The toll of health care: suicide risk among professionals

    Michele Luckenbaugh
  • Embracing life’s purpose in the face of inevitable death

    Michael Brant-Zawadzki, MD
  • From ICU to kidney mass: a nurse’s journey of fear

    Debbie Moore-Black, RN
  • Intravenous immunoglobulin for gastroparesis: What happened to me

    Maria Jay
  • Most Popular

  • Past Week

    • Health care’s hidden problem: hospital primary care losses

      Christopher Habig, MBA | Policy
    • The dark role of science, medicine, and tasers

      L. Joseph Parker, MD | Physician
    • From fishing licenses to gun control

      Mitch Bruss, MD | Policy
    • 3 key things to do before year end to reduce taxes

      Amarish Dave, DO | Finance
    • How to select the right mutual funds for your goals

      Amarish Dave, DO | Finance
    • Physicians turn feelings of frustration and powerlessness into purpose and hope

      Kim Downey, PT | Physician
  • Past 6 Months

    • Medicare coverage saves lives. Enrolling shouldn’t be this complicated.

      Catherine L. Chen, MD, MPH | Physician
    • The erosion of compassion in medicine

      Daniel Luger, MD | Education
    • Emergency department burnout: a cry for change

      Anonymous | Conditions
    • Health care’s hidden problem: hospital primary care losses

      Christopher Habig, MBA | Policy
    • Pain medicine realities: beyond the opioid crisis

      Richard A. Lawhern, PhD and Stephen E. Nadeau, MD | Conditions
    • When medical protocol meets family concerns

      Richard Young, MD | Conditions
  • Recent Posts

    • How to select the right mutual funds for your goals

      Amarish Dave, DO | Finance
    • America’s pain management nightmare: How the DEA shaped the opioid epidemic

      L. Joseph Parker, MD | Physician
    • The middleman dilemma in health care

      Anonymous | Physician
    • Tips for success as a plastic surgeon [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why write? Physicians share their stories of healing through writing.

      Kim Downey, PT | Physician
    • A complex patient interviews a retired physician

      Ann McColl and James Whitlock, MD | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • 'You Can't Take the Pot Off the Fire': What We Heard This Week
  • Bispecific Antibody Combination Active in Metastatic HR+/HER2+ Breast Cancer
  • Grappling With Our Deadliest Cancer
  • Benefits of Myeloma Regimens in the Real World Fall Well Short of Trials
  • Completely Oral Regimen Effective, Feasible in APL

Meeting Coverage

  • Bispecific Antibody Combination Active in Metastatic HR+/HER2+ Breast Cancer
  • Benefits of Myeloma Regimens in the Real World Fall Well Short of Trials
  • Completely Oral Regimen Effective, Feasible in APL
  • Less-Frequent Surveillance Mammo Feasible in Older Breast Cancer Survivors
  • Bilateral Mastectomy Not Tied to Better Survival in BRCA1-Positive Breast Cancer
  • Most Popular

  • Past Week

    • Health care’s hidden problem: hospital primary care losses

      Christopher Habig, MBA | Policy
    • The dark role of science, medicine, and tasers

      L. Joseph Parker, MD | Physician
    • From fishing licenses to gun control

      Mitch Bruss, MD | Policy
    • 3 key things to do before year end to reduce taxes

      Amarish Dave, DO | Finance
    • How to select the right mutual funds for your goals

      Amarish Dave, DO | Finance
    • Physicians turn feelings of frustration and powerlessness into purpose and hope

      Kim Downey, PT | Physician
  • Past 6 Months

    • Medicare coverage saves lives. Enrolling shouldn’t be this complicated.

      Catherine L. Chen, MD, MPH | Physician
    • The erosion of compassion in medicine

      Daniel Luger, MD | Education
    • Emergency department burnout: a cry for change

      Anonymous | Conditions
    • Health care’s hidden problem: hospital primary care losses

      Christopher Habig, MBA | Policy
    • Pain medicine realities: beyond the opioid crisis

      Richard A. Lawhern, PhD and Stephen E. Nadeau, MD | Conditions
    • When medical protocol meets family concerns

      Richard Young, MD | Conditions
  • Recent Posts

    • How to select the right mutual funds for your goals

      Amarish Dave, DO | Finance
    • America’s pain management nightmare: How the DEA shaped the opioid epidemic

      L. Joseph Parker, MD | Physician
    • The middleman dilemma in health care

      Anonymous | Physician
    • Tips for success as a plastic surgeon [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why write? Physicians share their stories of healing through writing.

      Kim Downey, PT | Physician
    • A complex patient interviews a retired physician

      Ann McColl and James Whitlock, MD | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...